These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 33020245)

  • 1. Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy.
    Rodrigues Mantuano N; Natoli M; Zippelius A; Läubli H
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity.
    Bärenwaldt A; Läubli H
    Expert Opin Ther Targets; 2019 Oct; 23(10):839-853. PubMed ID: 31524529
    [No Abstract]   [Full Text] [Related]  

  • 3. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
    Daly J; Carlsten M; O'Dwyer M
    Front Immunol; 2019; 10():1047. PubMed ID: 31143186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glyco-immune checkpoints for cancer therapy.
    Manni M; Läubli H
    Expert Opin Biol Ther; 2021 Aug; 21(8):1063-1071. PubMed ID: 33502268
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.
    Adams OJ; Stanczak MA; von Gunten S; Läubli H
    Glycobiology; 2018 Sep; 28(9):640-647. PubMed ID: 29309569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.
    Thurin M
    Monoclon Antib Immunodiagn Immunother; 2021 Jun; 40(3):89-100. PubMed ID: 34161162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.
    Ibarlucea-Benitez I; Weitzenfeld P; Smith P; Ravetch JV
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34155121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
    van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
    Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.
    Stanczak MA; Siddiqui SS; Trefny MP; Thommen DS; Boligan KF; von Gunten S; Tzankov A; Tietze L; Lardinois D; Heinzelmann-Schwarz V; von Bergwelt-Baildon M; Zhang W; Lenz HJ; Han Y; Amos CI; Syedbasha M; Egli A; Stenner F; Speiser DE; Varki A; Zippelius A; Läubli H
    J Clin Invest; 2018 Nov; 128(11):4912-4923. PubMed ID: 30130255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siglec receptors as new immune checkpoints in cancer.
    Stanczak MA; Läubli H
    Mol Aspects Med; 2023 Apr; 90():101112. PubMed ID: 35948467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling CD24-Siglec-10 pathway: Cancer immunotherapy from basic science to clinical studies.
    Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
    Immunology; 2024 Nov; 173(3):442-469. PubMed ID: 39129256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.
    Beckwith DM; Cudic M
    Semin Immunol; 2020 Feb; 47():101389. PubMed ID: 31926647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-Assisted Blockade of the Immune Suppressor Sialic Acid-Binding Immunoglobulin-Like Lectin-15 for Cancer Immunotherapy.
    Wu Q; Wei X; Chen F; Huang M; Zhang S; Zhu L; Zhou L; Yang C; Song Y
    Angew Chem Int Ed Engl; 2023 Dec; 62(52):e202312609. PubMed ID: 37955317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
    Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
    Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
    Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
    Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.
    Wisnovsky S; Möckl L; Malaker SA; Pedram K; Hess GT; Riley NM; Gray MA; Smith BAH; Bassik MC; Moerner WE; Bertozzi CR
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495350
    [No Abstract]   [Full Text] [Related]  

  • 17. Siglec and anti-Siglec therapies.
    Murugesan G; Weigle B; Crocker PR
    Curr Opin Chem Biol; 2021 Jun; 62():34-42. PubMed ID: 33607404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
    Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
    J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities.
    Haas Q; Markov N; Muerner L; Rubino V; Benjak A; Haubitz M; Baerlocher GM; Ng CKY; Münz C; Riether C; Ochsenbein AF; Simon HU; von Gunten S
    Front Immunol; 2022; 13():996746. PubMed ID: 36211376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of carbohydrate recognition during human sperm-egg binding.
    Clark GF
    Hum Reprod; 2013 Mar; 28(3):566-77. PubMed ID: 23315069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.